Petco Health and Wellness Company (WOOF) AI Stock Analysis

• Market Cap: $830.32M
• Dividend Yield: N/A
• Average Volume (3M): 3.14M
• Price to Earnings (P/E): ―
• Beta (1Y): 1.78
• Revenue Growth: -3.85%
• EPS Growth: 97.87%
• Country: US
• Employees: 29,000
• Sector: Consumer Cyclical
• Sector Strength: 84
• Industry: Specialty Retail
• EPS (TTM): 0.06
• Shares Outstanding: 246,564,870
• 10 Day Avg. Volume: 6,497,147
• 30 Day Avg. Volume: 3,140,124
• PEG Ratio: -0.76
• Price to Book (P/B): 0.65
• Price to Sales (P/S): 0.13
• P/FCF Ratio: 4.02
• Enterprise Value/Market Cap: 4.17
• Enterprise Value/Revenue: 0.58
• Enterprise Value/Gross Profit: 1.50
• Enterprise Value/Ebitda: 10.81
• 1Y Price Target: $3.84
• Price Target Upside: 13.61% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 10
• EPS Forecast (FY): 0.2
• Revenue Forecast (FY): $5.99B

• Rating: 54 Neutral
• Price Target: $3.00 ▼(-11.24% Downside)
• Action: Reiterated Date: 03/14/26
• Date: Action: Reiterated 03/14/26

The score is anchored by mixed financial performance—improving cash flow and margins but pressured revenue and still-meaningful leverage. Technicals are supportive with strong momentum, though overheated signals increase pullback risk. Valuation is weakened by negative earnings, while the latest earnings call supports the trend of operational improvement but with only modest sales growth guidance and ongoing execution/macro headwinds.

Positive Factors

Improving cash generation

A sharp recovery in operating and free cash flow provides durable internal funding for capex, inventory and debt paydown. Consistent positive OCF reduces refinancing pressure, supports reinvestment in omnichannel and services, and cushions execution risk during slow top-line recovery.

Gross margin expansion and cost discipline

Sustained gross margin expansion and SG&A leverage reflect assortment discipline, higher-mix private brands and operating efficiency. These structural margin gains increase profit resiliency versus sales volatility and create persistent operating leverage as sales stabilize or modestly grow.

Services and store ecosystem as durable moat

A branded services ecosystem (veterinary, grooming, training) generates frequent store visits, higher-margin revenue and sticky customer relationships. Embedded services plus omnichannel pickup strengthen retention and cross-sell, supporting steady revenue per customer over multiple years.

Negative Factors

Top-line weakness and slow revenue recovery

Guidance for only flat-to-low-single-digit sales growth signals a prolonged top-line recovery. Limited organic revenue momentum constrains scalability of investments, makes margin gains more dependent on cost cuts, and increases execution risk for initiatives that require customer adoption.

Leverage and meaningful interest expense

Elevated leverage and substantial recurring interest cost reduce financial flexibility and make free cash flow less available for growth. Continued debt servicing obligations can crowd out investment if sales lag, and refinancing risk persists until leverage meaningfully declines toward targets.

Inventory rebuild and working-capital pressure

Rebuilding inventory to support product newness raises working-capital needs and can pressure cash flow if sales do not ramp. For a leveraged retailer, higher inventory investment increases funding requirements and could slow pace of debt reduction or force tighter liquidity management.

Petco Health and Wellness Company Business Overview & Revenue Model

Company Description

Petco Health and Wellness Company, Inc., a health and wellness company, focuses on enhancing the lives of pets, pet parents, and its Petco partners. The company provides veterinary care, grooming, training, tele-health, and Vital Care and pet health insurance services, as well as veterinary services through Vetco mobile clinics. It also offers pet consumables, supplies, and services through its petco.com, petcoach.co, petinsurancequotes.com, and pupbox.com websites. As of March 23, 2022, the company operated approximately 1,500 Petco locations in the United States, Mexico, and Puerto Rico that included a network of approximately 200 in-store veterinary hospitals. Petco Health and Wellness Company, Inc. was founded in 1965 and is headquartered in San Diego, California.

How the Company Makes Money

Petco primarily makes money by selling pet products and pet services across its store base and e-commerce channels. The largest revenue driver is merchandise sales—especially consumables such as pet food and treats—supplemented by sales of hard goods (e.g., leashes, toys, habitats, and other supplies) and, where offered, sales related to companion animals. In addition to product retail, Petco earns service revenue from in-store offerings such as grooming and training. The company also generates revenue from veterinary-related offerings through its in-store veterinary presence, which includes company-operated and/or partner-operated clinic models depending on location; under these models, revenue can come from veterinary services provided directly and/or arrangements with veterinary partners. Across channels, recurring purchasing behavior (e.g., repeat consumables purchases and membership/loyalty engagement where applicable) supports sales frequency, while a mix of national brands and owned/private brands can influence gross margin and profitability. Specific partner names, revenue split details, and segment-level percentages are null.

Petco Health and Wellness Company Financial Statement Overview

Summary

Fundamentals are mixed: revenue has been declining recently and profitability has been volatile (large 2024 loss and only near-breakeven more recently). Leverage remains a constraint despite improvement, but operating cash flow is consistently positive and free cash flow rebounded strongly, providing some support.

Income Statement

Revenue has trended down recently (2026 annual revenue down ~0.6% and 2025 down ~2.2% after modest growth in 2023–2024), signaling demand/traffic pressure. Profitability is volatile: the company swung from solid profitability in 2022–2023 to a very large loss in 2024, then back to near-breakeven in 2026 (net margin ~0.2%). Gross margin has been relatively stable in the high-30% to low-40% range, but operating profitability remains thin, limiting resilience if costs rise or sales soften.

Balance Sheet

Leverage remains a key constraint. Debt-to-equity is elevated (about 2.7x in 2025 and ~1.2x in 2026, with prior years often above ~1.3x), which can pressure flexibility and increase refinancing risk in a higher-rate environment. Equity has also declined versus 2022–2023 levels, and returns on equity have been weak/negative in several years (notably 2024–2025), though 2026 shows a small positive return as earnings recovered.

Cash Flow

Cash generation is a relative bright spot. Operating cash flow is consistently positive across the period and improved in 2026 (about $314M). Free cash flow also rebounded strongly in 2026 (positive and sharply higher versus prior year), following weaker/negative results in 2024. The main weakness is that cash flow has not consistently translated into strong coverage versus overall obligations (coverage ratio remains low across years), so while liquidity generation is improving, balance-sheet leverage still matters.

Breakdown	Jan 2026	Jan 2025	Jan 2024	Jan 2023	Jan 2022
Income Statement
Total Revenue	5.96B	6.12B	6.26B	6.04B	5.81B
Gross Profit	2.31B	2.32B	2.35B	2.43B	2.43B
EBITDA	317.14M	7.05M	-971.83M	407.75M	452.22M
Net Income	9.07M	-101.82M	-1.28B	90.80M	164.42M
Balance Sheet
Total Assets	5.17B	5.19B	5.36B	6.61B	6.50B
Cash, Cash Equivalents and Short-Term Investments	256.74M	165.76M	125.43M	201.90M	211.60M
Total Debt	2.86B	2.96B	3.04B	3.13B	3.05B
Total Liabilities	4.01B	4.08B	4.18B	4.23B	4.24B
Stockholders Equity	1.16B	1.11B	1.18B	2.38B	2.27B
Cash Flow
Free Cash Flow	186.95M	49.68M	-9.88M	67.98M	119.11M
Operating Cash Flow	314.05M	177.67M	215.72M	346.00M	358.21M
Investing Cash Flow	-124.56M	-123.90M	-207.44M	-320.32M	-237.08M
Financing Cash Flow	-101.75M	-8.75M	-85.35M	-33.84M	-18.78M

Petco Health and Wellness Company Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 3.38
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For WOOF, the sentiment is Neutral. The current price of 3.38 is above the 20-day moving average (MA) of 2.75, above the 50-day MA of 2.75, and above the 200-day MA of 3.10, indicating a neutral trend. The MACD of 0.15 indicates Negative momentum. The RSI at 52.69 is Neutral, neither overbought nor oversold. The STOCH value of 54.95 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for WOOF.

Petco Health and Wellness Company Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CHWY	63 Neutral	$9.70B	57.58	55.17%	―	9.80%	-46.84%
Sector *	61 Neutral	$18.38B	12.79	-2.54%	3.03%	1.52%	-15.83%
WOOF	54 Neutral	$830.32M	-73.45	0.79%	―	-3.85%	97.87%
TDUP	53 Neutral	$414.14M	-38.47	-34.47%	―	-4.90%	50.77%
NHTC	51 Neutral	$24.10M	-15.12	-3.23%	25.20%	-5.07%	-115.50%
FLWS	47 Neutral	$192.84M	0.88	-67.22%	―	-8.07%	-2206.16%
BARK	44 Neutral	$113.43M	-3.00	-35.90%	―	-7.61%	-18.41%

Petco Health and Wellness Company Corporate Events

Petco Highlights 2025 Profitability Gains Amid Sales Decline

On March 11, 2026, Petco reported fourth quarter and full year 2025 results showing lower sales but sharply improved profitability after an operational reset. For 2025, net sales fell 2.5% to $6.0 billion and comparable sales declined 1.6%, yet gross margin expanded, operating income rose to $120.4 million from $7.1 million and net income swung to $9.1 million from a $101.8 million loss.

Fourth quarter net sales declined 2.4% to $1.5 billion, but operating income surged 83.2% and adjusted EBITDA grew 10.6%, coming in well above outlook as the retailer closed a net seven stores to end the year with 1,382 locations. Management highlighted stronger cash generation, a leverage ratio reduced from 4.2x to 3x, and a completed debt refinancing extending maturities to 2031, while guiding 2026 net sales to flat-to-modest growth, higher adjusted EBITDA and an additional 15–20 net store closures.

The most recent analyst rating on (WOOF) stock is a Buy with a $4.00 price target. To see the full list of analyst forecasts on Petco Health and Wellness Company stock, see the WOOF Stock Forecast page.

Petco Completes Debt Refinancing, Strengthens Financial Flexibility

On January 30, 2026, Petco’s board appointed Executive Chairman Glenn Murphy to serve as non‑employee Chairman of the Board effective February 1, 2026, with Murphy receiving a small statutory lump-sum payment tied to his prior offer letter and remaining eligible for a fiscal 2025 bonus. In a February 2, 2026 press release, the company also announced the successful closing of its previously disclosed long‑term debt refinancing, which management said has strengthened Petco’s economic model, improved profitability and cash flow, and is expected to reduce leverage and provide greater financial flexibility, reinforcing the retailer’s efforts to reset its capital structure and board leadership as it pursues its next phase of growth under CEO Joel Anderson and Murphy in his new governance-focused role.

The most recent analyst rating on (WOOF) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on Petco Health and Wellness Company stock, see the WOOF Stock Forecast page.

Petco restructures debt with new loans and notes

On February 2, 2026, Petco Health and Wellness Company, Inc. amended its first lien credit agreement to obtain $900 million in new refinancing term loans, which, together with cash on hand and the proceeds of a concurrent $600 million issuance of 8.250% senior secured notes due 2031, were designated to repay its existing term loan facility and adjust its capital structure. The new term loans, bearing interest at a margin of 4.25% over a term benchmark rate (or an alternative base rate plus 3.25%), include a six‑month 1% soft call premium, 1% annual amortization, and a five‑year maturity, while the newly issued notes are governed by an indenture that imposes restrictive covenants on additional indebtedness, dividends, asset sales, liens, affiliate transactions, and certain corporate restructurings, with defined redemption options and change‑of‑control protections, collectively reshaping the company’s debt profile and tightening operating and financing flexibility for stakeholders.

The most recent analyst rating on (WOOF) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on Petco Health and Wellness Company stock, see the WOOF Stock Forecast page.

Petco Prices $600 Million Senior Secured Notes Offering

On January 22, 2026, Petco Health and Wellness Company announced it had priced a $600 million offering of senior secured notes due February 1, 2031, carrying an interest rate of 8.25%, with the transaction expected to close on February 2, 2026 subject to customary conditions. The notes, guaranteed by Petco’s credit-facility guarantor subsidiaries and secured by first-lien interests in fixed assets and second-lien interests in current assets, will rank ahead of the company’s unsecured and junior-lien debt to the extent of the collateral, while remaining effectively subordinated to certain other secured obligations, and the proceeds, alongside a new term loan and cash on hand, are earmarked to refinance Petco’s existing term loan facility, cover related fees and bolster general corporate liquidity, signaling a significant move to reprofile its capital structure and manage its debt obligations.

The most recent analyst rating on (WOOF) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on Petco Health and Wellness Company stock, see the WOOF Stock Forecast page.

Petco Launches $650 Million Senior Secured Notes Offering

On January 21, 2026, Petco announced it had commenced an offering of $650 million in senior secured notes due 2031, guaranteed by subsidiaries that back its credit facilities and secured by first-lien interests on fixed assets and second-lien interests on current assets. The company plans to use the proceeds, together with borrowings under a new term loan and cash on hand, to fully repay its existing term loan facility, cover related fees and expenses, and fund general corporate purposes, a move that is set to reshape its debt profile by replacing existing financing with a new mix of secured notes and loan funding aimed at strengthening its capital structure and financial flexibility for stakeholders.

The most recent analyst rating on (WOOF) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on Petco Health and Wellness Company stock, see the WOOF Stock Forecast page.

Petco Launches Major Debt Refinancing, Reaffirms 2025 Outlook

On January 12, 2026, Petco announced the launch of a debt refinancing transaction aimed at extending the maturities on $1.5 billion of its existing term loan, following a $50 million voluntary prepayment made in December 2025 and with the option to make further prepayments under a $100 million board authorization, signaling an effort to optimize its capital structure amid ongoing market uncertainty. In connection with the refinancing, the company reaffirmed its guidance for the fourth quarter and full fiscal year 2025 ending January 31, 2026, projecting net sales to decline 2.5%–2.8% for the year with low single-digit declines in the fourth quarter and forecasting Adjusted EBITDA of $395 million–$397 million for fiscal 2025 and $93 million–$95 million for the quarter, underscoring management’s confidence in operational performance and category resilience despite softer top-line trends.

The most recent analyst rating on (WOOF) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on Petco Health and Wellness Company stock, see the WOOF Stock Forecast page.